The main instrument for the effective interaction of business, science and the government for the benefit of the development of medical and pharmaceutical industries is Technology Platform “Medicine of the Future” a Strategic research program for 2012 -2020, with prospects up to 2030”.
Strategic Research Program (SRP) – is a long-term program of applied researches and developments to create new biomedical products and technologies aimed at addressing the most pressing health issues.
The main objects of the Program are:
1. Develop a set of technologies that can make the resource and ideological basis for scientific and technological “breakthrough” and introduction of new high-tech products (services) markets.
2. Ensure introduction, expertise and support of complex scientific programs focusing on the creation of high-tech products (services).
3. Develop and support at the global level of the basic research and methodical systems in biomedicine, pharmacy, new materials for medicine, medical instrumentation due to the accumulation and management of the available material and technical resources of research institutes and universities of the Russian Federation.
4. Provide staff training for all stages of the of innovative product creation, including the intersection of sciences for projects on the basis of convergent technologies in the field of medicine and pharmaceuticals.
SRP is a fundamental mechanism for the implementation of medium-and long-term priorities of biomedicine based on cross-industry technology development, coordination of participants in the development and implementation of complex programs of a full cycle.